55. CMA and concurrent karyotyping for MCA, ASD, and/or DD/ID patients: Cost effectiveness based on our 7-year experienceMeng Su,Stephanie Page,Mary Haag,Karen Swisshelm,Deborrah Hennerich,Sharon Graw,Jamie LeRoux,Peter Brzeskiewicz,Shayna Svihovec,Liming BaoCancer Genetics(2022)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要